Resources
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency
The FDA accepted Eton Pharmaceuticals' NDA for ET-600 for pediatric arginine vasopressin deficiency, with a target action date in February of 2026.
Food Insecurity and the Dangers of Infant Formula Dilution
AAP, other medical societies sue HHS, Robert F. Kennedy Jr. over vaccine practices
Six medical societies, including the American Academy of Pediatrics, are suing the HHS and its Secretary to "defend vaccine policy."
Demystifying Infant Formula
Weekly review: Label changes to maralixibat, pediatric mental health data, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Key FDA approvals in pediatric health: First half of 2025
A roundup of the most impactful FDA approvals in pediatric health from January through June 2025, spanning diagnostics, therapeutics, and at-home care.